Kentucky Risperdal Claim Settled for $15.5M

 

On December 22, 2015, Janssen Pharmaceuticals and its parent company, Johnson & Johnson, entered into a settlement with the Commonwealth of Kentucky, agreeing to pay $15.5 million to the state, sufficiently disclose the associated risks of the dr Read More »

Filter News

No-Obligation Free Consultation

Contact us by phone at 1-888-508-6752 or email us below.